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What´s new?  
We systematically investigated interactions between attained age and metabolic factors in 
relation to cancer risk. For female breast cancer and liver cancer among men, elevated BMI 
and triglycerides were associated with decreased risks in younger ages and increased risks in 
older ages with linearly changing patterns of associations across age. The findings for liver 
cancer are novel, and the linearly changing associations across age for breast cancer suggest 
that other age-related factors than menopause per se modify the associations between 
metabolic factors and breast cancer risk. 
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Abstract 
Apart from the consistently observed differential association between obesity and breast 
cancer risk by menopausal status, the associations between obesity and other metabolic 
imbalances with risks of cancers have not been systematically investigated across the age-
course. We created two random 50-50% cohorts from six European cohorts comprising 
813,927 individuals. In the “discovery cohort”, we used Cox regression with attained age as 
time-scale and tested interactions between body mass index (BMI), blood pressure, plasma 
glucose, triglycerides and cholesterol, and attained age in relation to cancer risk. Results 
with a P-value below 0.05 were additionally tested in the “replication cohort” where a 
replicated result was considered evidence of a linear interaction with attained age. These 
findings were investigated by flexible parametric survival models for any age-plateaus in 
their shape of associations with cancer risk across age. Consistent with other studies, BMI 
was negatively related to breast cancer risk (n cases=11,723) among younger 
(premenopausal) women. However, the association remained negative for several years 
after menopause and, although gradually weakening over age, the association became 
positive only at 62 years of age. This linear and positive age-interaction was also found for 
triglycerides and breast cancer, and for BMI and triglycerides in relation to liver cancer 
among men (n cases=444). These findings are unlikely to be due to chance owing to the 
replication. The linear age-interactions in breast cancer may suggest an influence by other 
age-related factors than menopause; however, further investigation of age-related effect 
modifiers in both breast and liver cancer is needed. 
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Introduction 
Obesity is an established risk factor for a range of different cancers, including cancer of the 
oesophagus, colorectum, liver, kidney, multiple myeloma, and endometrium.1 The shape of 
the associations between obesity and cancers have been investigated in detail across the 
exposure range allowing for non-linear associations,2, 3 but potential differential associations 
across the age-course have not been specifically investigated. Menopause occurs at around 
50 years of age, and female hormone-related cancers, especially breast cancer, have 
commonly been investigated separately by menopausal status. Obesity has been 
consistently related to a decreased breast cancer risk before menopause and an increased 
risk after menopause.2-4 In our previous study of breast cancer, we found a similar pattern of 
association also for plasma triglycerides and risk at pre- and postmenopausal ages.5  
Most cohort studies of metabolic factors and cancer risk have used Cox 
proportional hazards regression, which assumes a constant multiplicative effect of the risk 
factor over time, i.e. proportional hazards (PH). Violation of PH when using age as time-
scale, which is commonly used in studies of cancer risk, indicates that the hazard ratio (HR) 
for the violated factor varies by attained age. However, the reporting of PH assumption tests 
and of age-dependent results in case of violation of the main exposure have been lacking in 
survival studies overall,6, 7 and to our knowledge, no previous study has systematically 
assessed whether risk for cancer at different sites due to metabolic factors vary across 
attained age.  
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The aim of this study was to systematically investigate whether the 
associations between metabolic factors (body mass index [BMI], blood pressure, and plasma 
glucose, triglycerides and total cholesterol) and risks for a range of cancer forms vary across 




We used data from the Metabolic syndrome and Cancer project (Me-Can) 2.0, which pools 
six cohorts with recruitment periods as follows: in Norway, Oslo I (1972-73), the Norwegian 
Counties Study (NCS, 1974-88) and the 40-year programme (40-y, 1985-99); in Sweden, the 
Västerbotten Intervention Project (VIP, 1985-ongoing) and the Malmö Preventive Project 
(MPP, 1974-92); and in Austria, the Vorarlberg Health Monitoring and Prevention 
Programme (VHM&PP, 1985-2005). The project is a continuation of Me-Can 1.0, which has 
been extensively described previously with regards to the purpose, population, and 
measurements of included cohorts.8 In contrast to Me-Can 1.0 on which Me-Can 
publications in 2009-2015 were based,8 Me-Can 2.0 does not include Cohort of Norway 
(CONOR), but it includes the full Oslo I, NCS, and 40-y cohorts. Me-Can 2.0 also includes 
additional individuals and health observations in the VIP between the years 2006 and 2014 
and in the VHM&PP between the years 2003 and 2005. Questionnaire information on 
tobacco use and number of years smoking were also added to the Me-Can database, as well 
as other variables that, however, are not available in all cohorts. Measurement methods of 
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metabolic factors have been previously described in detail for all cohorts,8 which in the VIP is 
valid for measurements performed before Sept 1, 2009, after which, however, the 
measurement methods for blood pressure and plasma lipids changed. Before that date, 
blood pressure was measured in supine position, and was thereafter measured in sitting 
position. Plasma cholesterol and triglycerides were measured on a Reflotron bench-top 
analyzer at the examining health care centre before Sept 1, 2009, and were thereafter 
measured at the Clinical Chemistry department at the nearest hospital using standard 
enzymatic methods. For research purposes, formula have been developed to transform 
levels between new and old measurement methods of blood pressure and plasma lipids, 
which we used in the present study. These formula were based on individuals with 
measurements using both old and new measurements methods (n=838 for triglycerides, 
1,197 for cholesterol, and 648 for blood pressure). Triglyceride and cholesterol levels 
measured on Sept 1, 2009 onwards were converted to old measurement levels using the 
formulas: 0.177 + (0.932 × triglyceride level) and 0.170 + (0.939 × cholesterol level). Formula 
for blood pressure were age- and sex-specific (Supplementary Table 1). The study was 
approved by ethical committees in Norway, Sweden, and Austria.  
 
Follow-up 
Individuals in the cohorts were linked to their respective national cancer register, or regional 
cancer register for the VHM&PP, and national cause of death register for information on 
cancer diagnoses and death causes. The Norwegian and Swedish cohorts were additionally 
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linked to their respective national total population register for information on emigration. 
Follow-up included the year 2012 in Norway and 2014 in Sweden and Austria, which was an 
extension of seven (Austria), eight (Sweden), or eleven (Norway) years of follow-up for 
cancer diagnoses compared to in Me-Can 1.0. We used the 7th revision of the International 
Classification of Diseases (ICD-7) to categorise cancers. All malignant cancers, except 
basalioma, were included, as well as blood cancers (ICD-7 200-209) of uncertain or unknown 
behavior. In situ cancers were excluded except urothelial carcinoma in situ, which were 
included because they frequently progress to higher stage and muscle-invasive tumours.9, 10  
 
Selection criteria 
Amongst 843,522 individuals with 1,557,855 health observations in Me-Can 2.0, we selected 
813,927 individuals with one observation each (Figure 1). The largest number of exclusions 
were performed due to a prevalent cancer (26,158 observations), non-fasting status during 
the first three years in the VHM&PP (77,031 observations), missing data on fasting status 
(29,842 observations), and the selection of one observation amongst individuals with more 
than one observation, in which case we selected the first health observation with complete 
data on metabolic factors and with a fasting state if that was available (609,143 
observations). The relatively large number of observations with fasting status missing were 
primarily a result of not requesting information on fasting status. Out of the 302 individuals 
excluded due to an older age than 100 years at the end of follow-up, 300 originated from the 
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VHM&PP in which missing emigration data might have caused a minor loss to follow-up and 
thus immortalised individuals in the dataset.  
 
Statistical analysis 
We investigated metabolic factors (BMI, blood pressure, glucose, cholesterol, and 
triglycerides) transformed to standardized exposures (Z score) with a mean value of zero and 
a standard deviation (SD) of one using the formula: (metabolic level-mean)/SD within 
subgroups of sex, cohort and fasting time (<4h, 4-7 h, and ≥8 h), except blood pressure that 
was standardized by sex and cohort only. Triglycerides and glucose had skewed distributions 
so their values were log-transformed before standardisation. Blood pressure was 
investigated as mid-blood pressure, i.e. the average of systolic plus diastolic blood 
pressure.11 In all analyses, we excluded individuals with values more extreme than ±3 SDs of 
the main exposure (maximum 1.3% of individuals).  
 We investigated linear interactions between metabolic factors and attained 
age, and cancer risk for cancer forms with at least 400 incident cases separately among men 
or women. Individuals in the study were followed from one year after baseline in order to 
reduce the risk for reverse causation, until the date of first cancer diagnosis, emigration, 
death, or end of follow-up, whichever occurred first. For cancers of the liver, pancreas, and 
kidney (renal cell), which are both subject to longer latency periods before clinical diagnosis 
and for which an existing tumour might affect metabolic levels, we additionally explored the 
impact of excluding the first six years of follow-up. We used Cox regression with attained age 
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as time-scale, and included a time-dependent product term of attained age and a metabolic 
factor as interaction variable in the analysis to assess the linear exposure-age interaction.12 
We adjusted for continuous baseline age and seven categories of smoking (never-smoker, 
ex-smoker, smokers in tertiles of pack-years, smokers with pack-years missing [7.0% of 
smokers], and missing smoking status [0.3%]). Our recent study in the VIP and the VHM&PP 
of the relationship between the five metabolic factors investigated in the present study 
showed that BMI was overall modestly correlated with the other metabolic factors and, out 
of the metabolic factors investigated, was the strongest determinant for future change of 
another metabolic factor.13 Therefore, in the present study, analyses of metabolic exposures 
other than BMI were additionally adjusted for BMI continuous Z score. The model was 
stratified by cohort and birth cohort (before 1923, 1923-30, 1931-38, 1939-46, 1947-54, 
1955 and later), and additionally by quintiles of baseline age or by smoking categories if any 
of these factors interacted linearly with attained age (P-value<0.05 in Supplementary Table 
2).  
To avoid false positive interactions, metabolic exposure-age interactions were 
evaluated using an internal replication approach. We split the population into two random 
50-50% datasets, one “discovery cohort” and one “replication cohort”, and tested one 
exposure-age interaction at a time in the discovery cohort. Results with P-values below 0.05 
were additionally tested in the replication cohort, out of which results with a P-value below 
0.05 were considered evidence of an interaction. For confirmed findings in the replication 
cohort, we further investigated the findings in the full study population. First, we calculated 
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the linear age-interaction estimates and derived HRs at specific ages and the age at which 
the HRs crossed 1.0. Second, we plotted HRs over attained age in the full study population 
by using cubic splines of the studied time-interaction variable in flexible parametric survival 
models.14 This model is similar to the Cox model but the baseline hazard function is 
estimated parametrically using cubic splines. We used the same adjustments as in the Cox 
models, but additionally adjusted for cohort and birth cohort as the flexible parametric 
survival model software does not allow for stratification.  
In relation to the findings for BMI and triglycerides and breast cancer among 
women and liver cancer among men, we performed a number of posthoc and sensitivity 
analyses by use of flexible parametric survival models. We calculated age-dependent HRs in 
relation to levels of blood pressure, glucose and cholesterol in order to see whether the 
patterns of associations for these factors would be similar to those of BMI and triglycerides. 
We also tested flexible parametric survival models in relation to breast cancer using various 
degrees of freedom for the cubic splines of the age-dependent associations for BMI and 
triglycerides. The results showed largely similar patterns but, naturally, with larger flexibility 
of the spline with increasing degrees of freedom (Supplementary Figure 1). The Akaike 
Information Critera and Bayesian Information Criteria were used to assess the best fit of the 
tested models,14 and the lowest values were found for the model with one degree of 
freedom for both breast and liver cancer (Supplementary Table 3). This indicates that the 
age-dependent associations can be expressed as a linear function of log time, however, the 
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other models had very similar fitted values. In all models, four degrees of freedom were 
used to model the spline of the baseline hazard.  
Posthoc and sensitivity analyses of age-dependent HRs for BMI and 
triglycerides were also performed for a) liver cancer of men and women combined, b) breast 
cancer in subgroups of age at measurement: <40 years, 40-49 years and ≥50 years, c) breast 
cancer with adjustments for age at first delivery (no child, <20 years, 20-24 years, 25-29 
years, 30-34 years, and ≥35 years) and number of deliveries (0, 1, 2, 3, and ≥4) based on 
nation-wide registry data in Sweden and Norway (the multi-generation register and the 
national tax registry), and d) breast and liver cancer with adjustment for plasma gamma 
glutamyl-transferase as a moderate and objective marker for (heavy) alcohol 
consumption,15-17 but also for non-alcoholic fatty liver disease. In the latter analysis, we 
adjusted for quartiles of gamma glutamyl-transferase, in the MPP using separate cut-points 
by fasting time, and in the VHM&PP using separate cut-points by measurements performed 
before or after Jan 1 2003 when gamma glutamyl-transferase measurements had been 
changed. 
We also investigated the shape of associations between absolute BMI level and 
Z score of triglycerides and breast cancer risk in subgroups of attained age: <50 years, 50-59 
years, 60-69 years, and ≥70 years, by use of cubic splines in Cox models with the same strata 
and adjustments as in the previously described Cox models, with additional adjustment for 
cohort in analyses of BMI. We compared the fit of a linear model with the fit of the cubic 
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spline model by use of likelihood-ratio tests, in which the linear model was nested in a 
model that additionally included cubic splines. 
All statistical analyses were performed in STATA MP/2 version 15 (StataCorp 
LP, College Station, Texas). 
 
Results 
The mean baseline age among the 813,927 participants in the study was 43 years (SD=9), 
and 65% were 35 to 44 years old (Table 1). Mean BMI was 25 kg/m2 (SD=4), and 11% were 
obese (BMI ≥30 kg/m2). The proportion of smokers was 29% among women and 34% among 
men. Follow-up time was on average 20 years (SD=8), and exclusion of the first follow-up 
year in survival analysis resulted in 7,515,453 person-years among women and 7,611,787 
person-years among men. Participant characteristics were almost identical in the discovery 
and the replication cohort (Supplementary Table 4).  
Among women, P-values for age-dependent metabolic variables were below 
0.05 on seven occasions in the discovery cohort, which were replicated for BMI and 
triglycerides in relation to breast cancer risk (Supplementary Table 5). The corresponding 
finding among men was four in the discovery cohort, which was replicated for BMI and 
triglycerides in relation to liver cancer risk. In analyses of liver, pancreas and renal cell cancer 
excluding the first six years of follow-up, we found no significant age-interactions for any of 
the metabolic factors. For liver cancer among men, the P-values for age-interaction with BMI 
and triglycerides had increased to ≥0.05 in the discovery cohort, which may, however, have 
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been caused by limited statistical power in these analyses (n cases = 390 in the full cohort), 
as well as in the analyses of pancreas and renal cell cancer (n cases within the first follow-up 
years are shown in Supplementary Table 6).  
Table 2 shows HRs at specific ages for BMI and triglycerides in relation to 
female breast and male liver cancer derived from linear interaction models with age 
(Supplementary Table 7). Higher levels of BMI and triglycerides were risk factors only at 
older ages and were negatively related to risk at younger ages. The age at which HRs crossed 
1.0 was for breast cancer 62 years for BMI and 66 years for triglycerides, and for liver cancer 
among men 53 years for BMI and 72 years for triglycerides. HRs over attained age for BMI 
and triglycerides are shown in Figure 2 in relation to female breast cancer, and in Figure 3 in 
relation to liver cancer among men. For liver cancer, the age-interaction with BMI and 
triglycerides became less clear with the inclusion of women (n cases=209) (Supplementary 
Figure 2). HRs across age for mid-blood pressure, glucose, and cholesterol in relation to 
breast cancer among women and liver cancer among men are shown in Supplementary 
Figures 3 and 4.  
The effect of interaction with attained age for BMI, triglycerides and breast 
cancer risk showed minor differences between subgroups of baseline age (Supplementary 
Figure 5), and minor influence by additional adjustment for parity and age at first birth 
(Supplementary Figure 6), or plasma gamma glutamyl-transferase level (Supplementary 
Figure 7). For liver cancer, adjustment for gamma glutamyl-transferase did not change the 
 
 
This article is protected by copyright. All rights reserved.
 
interactions between BMI, triglycerides and attained age, but HRs were attenuated 
(Supplementary Figure 8). 
For female breast cancer, we further plotted the shapes of associations across 
the exposure scales of BMI in absolute levels and Z score of triglycerides in relation to risk in 
subgroups of attained age (Figure 4). The associations were approximately linear within each 
age-group (P-values comparing the Cox spline model with a linear model were ≥0.22 and 
≥0.12, for BMI and triglycerides, respectively) and showed gradually changing patterns of 
associations with increasing age. 
 
Discussion 
We systematically investigated the interaction between metabolic factors and attained age 
in relation to cancer risk in a large European study and found that BMI and triglycerides 
interacted positively with age in relation to breast cancer among women and liver cancer 
among men. Higher levels of BMI and triglycerides were related to a decreased risk for 
breast cancer before 62 and 66 years of age, but with an increased risk after that age. For 
male liver cancer, the age cut-points were at 53 and 72 years, respectively. However, rather 
than drastic changes of associations around these ages, and inherent to the linear tests 
performed to detect interactions, HRs for these metabolic factors changed linearly across 
the age-course.  
Apart from breast cancer, we had no expectations of age-dependent 
associations with specific cancer forms. This hypothesis-free approach together with the 
 
 
This article is protected by copyright. All rights reserved.
 
many tests performed (n=185) required correction for multiple testing. Without such 
correction, about nine false positive findings using 5% alpha-level would have been expected 
in our study. Bonferroni correction or its derivates are often used to correct for multiple 
testing,18 but due to their one-off corrections of P-values, a very low P-value is required to 
reach significance. Additionally, these methods do not consider varying statistical power of 
each test, such as per cancer site in our study. Therefore, we used replication, which is 
common practice in genome-wide association studies discovering new gene loci for diseases 
or traits. Relative to other standard correction methods,18 our replication approach enabled 
us to increase the chances of positive findings especially for rarer cancers, whilst also 
reducing the risk of false positives. However, we cannot exclude the possibility of false 
positive or negative findings, especially for rarer cancer forms with lower statistical power.  
Our results for BMI and breast cancer correspond with the large number of 
observational studies suggesting a negative association between BMI and breast cancer risk 
before menopause but a positive association after menopause.2-4 The division at menopause 
in studies of obesity is motivated by a plausible biological explanation for the association 
after menopause, at the same time, the biological support is much weaker for the negative 
association before menopause.3, 19, 20 Two recent Mendelian randomization studies 
evaluated the potential causal association between BMI and breast cancer risk, and showed 
negative associations with breast cancer risk regardless of menopausal status.21, 22 The 
authors speculated that the timing of obesity measurement might explain the divergent 
findings compared to observational studies. This, however, found no support in our study 
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(Supplementary Figure 5), though our youngest age-group might have been too old to 
capture young adulthood. However, results in our study provide an alternative explanation 
for the seemingly differential associations by study design. Higher BMI levels, especially 
obese levels (BMI ≥30 kg/m2), decreased the risk for breast cancer an additional number of 
years after menopausal age, and the association changed continuously across age. This 
suggests that other age-related factors than menopause per se may cause the age-
dependent association between obesity and breast cancer. The reasons for this is unclear, 
and one potential explanation may be that older women are more frequently diagnosed 
with estrogen and progesterone-receptor-positive breast tumours, which has shown a 
complex association with obesity.23-25  
Our findings for triglycerides and breast cancer risk were similar to those for 
BMI, and likewise, results from observational studies of triglycerides reflected those of BMI 
with a graded association by menopause or menopausal age.5, 26, 27 The largest study to date 
on triglycerides and breast cancer risk showed a suggestive negative association in a 
population of women who, at diagnosis, were primarily in their early postmenopausal 
ages.28 These findings are supported in a recent Mendelian randomization study,29 with a 
mean age of 66.5 years at breast cancer diagnosis (unpublished data in reference no. 29), i.e. 
the age at which the HR for triglycerides crossed 1.0 in our study. Thus, the present study 
and emerging evidence in recent studies suggest a similar age-dependent association 
between triglycerides and breast cancer risk to that of obesity and breast cancer, which may 
not depend on menopause.  
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The causes for our findings on liver cancer are unclear and may have several 
explanations. The male to female incidence ratio of liver cancer ranges from 2:1 to 4:1 across 
populations,30 which has been hypothesized to be caused by a higher prevalence of strong 
risk factors among men including hepatitis B and C virus infection, alcohol intake, smoking, 
and also potentially by sex hormones.31 Moreover, obesity has been related to an increased 
liver cancer risk among men in particular, which may suggest an influence by sex-specific 
effect modifiers.32 Our results additionally suggest that such effect modifiers are age-related. 
Estrogens may be involved in liver cancer,31 and whilst circulating estrogen levels increase 
with age among men,33 it decreases among women after menopause. Potentially, the higher 
estrogen levels among older men act in synergy with obesity and elevated triglycerides in 
relation to risk. Alternatively, our results might reflect higher risks with a longer exposure to 
metabolic imbalances (correlated with higher age), as has been found for obesity duration in 
relation to several cancer forms among women.34 Alternatively, obesity and triglycerides 
may act in synergy with effect modifiers that increase in strength with a longer exposure 
duration, e.g. the aforementioned main risk factors for liver cancer. Finally, our results might 
also reflect differential associations between BMI, triglycerides, and different liver cancer 
tumours typically occurring in younger versus older age.35 
Weaknesses of our study include the use of a general obesity measure rather 
than abdominal obesity that is more specific in relation to metabolic imbalances, as well as 
the assessment of total cholesterol rather than its components. We also lacked complete 
data on potentially important confounders such as socioeconomic status, occupational 
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exposures, inflammatory markers, physical activity, and dietary intake including alcohol. 
However, analyses including adjustment for gamma glutamyl-transferase as an objective 
marker for alcohol intake15-17 did not change the patterns of associations for breast and liver 
cancer, but the overall lowered HRs for liver cancer presumably reflect alcohol as a 
confounder and/or liver damage and more specifically non-alcoholic fatty liver disease as 
one pathway to liver cancer.36, 37 Moreover, data on medications would have been desirable 
in our study, especially during follow-up given the relatively young population and long 
follow-up. Strengths of our study include the large population that provided robust risk 
estimates and facilitated the replication approach. Replicated age-exposure interactions 
using the Cox regression model were in addition modelled using non-linear models in order 
to detect possible effect of plateaus in the association. Moreover, we used high-quality 
registers to track and determine cancers,38-40 and we adjusted in detail for smoking, an 
important risk factor for several cancer forms. 
In conclusion, elevated BMI and triglycerides were related to decreased risks of 
breast cancer among younger women, but to increased risks among older women. The 
continuously changing associations across age rather than drastic changes around the age of 
menopause questions the notion that menopausal factors underlie the consistently 
observed differential associations between BMI and breast cancer risk before versus after 
menopause. Similar to breast cancer, BMI and triglycerides interacted positively with 
attained age in relation to liver cancer among men. These are unlikely to be chance findings 
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given the replication in the study, but the underlying causes are unknown and require 
further investigation in other studies. 
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Table 1. Baseline characteristics of the study population  
Characteristics Women (n=407,474) Men (n=406,453) 
Cohort, n (%)     
  Oslo   17,856 4 
  NCS 43,074 11 44,658 11 
  40y 209,776 51 192,971 47 
  VHM&PP 94,032 23 80,963 20 
  VIP 50,965 13 49,868 12 
  MPP 9,627 2 20,137 5 
Age, years     
  Mean (SD) 42.9 9.6 43.0 8.8 
  Categories, n (%)     
    <35 49,291 12 44,908 11 
    35-44 265,819 65 261,919 64 
    45-54  46,951 12 58,281 14 
    ≥55 45,413 11 41,345 10 
Smoking status, n (%)     
  Never-smoker 195,655 48 156,273 38 
  Ex-smoker 94,343 23 111,365 27 
  Smoker 116,191 29 137,338 34 
Fasting time, hours, n (%)     
  <4 208,623 51 205,260 51 
  4-7 38,806 10 43,050 11 
  ≥8 160,045 39 158,143 39 
Body mass index, kg/m2     
  Mean (SD) 24.6 4.3 25.6 3.4 
  Categories, n (%)     
    <25 254,545 63 188,970 47 
    25-29 107,942 27 176,160 44 
    ≥30 42,992 11 39,581 10 
Blood pressure, mm Hg     
  Mean (SD) systolic blood pressure 126 18 133 16 
  Mean (SD) diastolic blood pressure 77 11 82 10 
  Mean (SD) mid-blood pressureb 102 13 107 12 
  Categories, n (%)     
    <140 systolic and <90 diastolic blood pressure 314,363 77 255,396 63 
    140-159 systolic or 90-99 diastolic blood pressure 66,194 16 113,227 28 
    ≥160 systolic or ≥100 diastolic blood pressure 26,665 7 37,564 9 
Glucose, mmol/lc     
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  Mean (SD) 5.0 1.1 5.2 1.3 
  Categories, n (%)     
    <6.1 in serum/plasma, <5.6 in whole blood 142,967 92 134,917 89 
    6.1-6.9 in serum/plasma, 5.6-6.0 in whole blood 8,548 6 10,875 7 
    ≥7.0 in serum/plasma, ≥6.1 in whole blood 4,437 3 6,182 4 
Cholesterol, mmol/ld     
  Mean (SD) 5.5 1.2 5.6 1.2 
  Categories, n (%)     
    <5.2 70,263 44 61,436 39 
    5.2-6.1 50,377 32 52,725 33 
    ≥6.2 39,224 25 43,818 28 
Triglycerides, mmol/ld     
  Mean (SD) 1.2 0.8 1.6 1.2 
  Categories, n (%)     
    <1.7 132,497 83 106,252 68 
    1.7-2.2 16,002 10 24,166 16 
    ≥2.3 10,618 7 25,522 16 
Years of follow-up     
  Mean (SD) 19.4 7.3 19.7 8.1 
  Categories, n (%)     
    <5 16,249 4 18,520 5 
    5-14 86,551 21 89,708 22 
    15-24 229,918 56 214,449 53 
    ≥25 74,756 18 83,776 21 
Oslo, Oslo Study I; NCS, Norwegian Counties Study; 40y, Age 40 Programme; VHM&PP, Vorarlberg 
Health Monitoring and Prevention Programme; VIP, Västerbotten Intervention Project; MPP, Malmö 
Prevention Project; SD, standard deviation. 
aThe number (%) of participants with missing values were for: smoking status, 2,762 (0.3%); body 
mass index, 3,737 (0.5%); blood pressure, 518 (0.1%); glucose, 293,652 (36%); cholesterol, 866 (1%); 
and triglycerides 3,900 (5%). 
bMid-blood pressure defined as (systolic+diastolic blood pressure)/2. 
cIncludes participants who fasted >8 hours and who had glucose measured in serum or plasma, i.e. 
not participants in the MPP who had glucose measured in whole blood. 
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Table 2. Estimates of hazard ratios at specific ages, per standard deviation increase in BMI 
and triglycerides in relation to breast cancer in women and liver cancer in men, derived from 
results from Cox proportional hazards models in Supplementary Table 6. 
Age, years 
Breast cancer (N cases=11,723) Liver cancer (N cases=444) 
HR for BMIa HR for triglyceridesa HR for BMI
a HR for triglyceridesa 
30 0.79 0.86 0.64 0.53 
40 0.85 0.90 0.78 0.62 
50 0.92 0.94 0.95 0.72 
60 0.99 0.98 1.15 0.83 
70 1.06 1.02 1.39 0.96 
80 1.14 1.06 1.69 1.12 
90 1.22 1.10 2.04 1.30 
Age where 
HR=1b 62 66 53 72 
HR, hazard ratio; BMI, body mass index. 
aHazard ratio derived from time-interaction variable of the metabolic factor calculated in Cox models 
with age as time-scale, stratified for cohort and birth cohort (six categories), and adjusted for 
baseline age (continuous), smoking (seven categories), and continuous Z score for BMI (except for 
BMI). 
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Figure 1. Flowchart of exclusions and selections of individuals and health observations in the 
study.  denotes exclusions. Abbreviations: VIP, Västerbotten Intervention Project; MPP, 
Malmö Preventive Project; BMI, body mass index; VHM&PP, Vorarlberg Health Monitoring 
and Prevention Programme. 
 
 
Figure 2. Age-dependent hazard ratio with 95% confidence interval for breast cancer among 
women (N cases=11,723) per standard deviation increase in A) body mass index and B) 
triglycerides. Calculations are based on flexible parametric survival models with age as time 
scale and cubic splines for the age interaction, adjusted for cohort, birth cohort (six 
categories), baseline age (continuous), smoking (seven categories), and continuous Z score 
for BMI (except for BMI), with four degrees of freedom in the baseline hazard and three 
degrees of freedom in the time dependent effect of the metabolic factors.  
 
 
Figure 3. Age-dependent hazard ratio with 95% confidence interval for liver cancer among 
men (N cases=444) per standard deviation increase in A) body mass index and B) 
triglycerides. Calculations are based on flexible parametric survival models with age as time 
scale and cubic splines for the age interaction, adjusted for cohort, birth cohort (six 
categories), baseline age (continuous), smoking (seven categories), and continuous Z score 
for BMI (except for BMI), with in A) three degrees of freedom for the baseline hazard and 
two for the time dependent effect of body mass index and in B) two degrees of freedom for 
the baseline hazard and one for the time dependent effect of triglycerides. 
 
 
Figure 4. Hazard ratio of breast cancer among women for levels of A) body mass index (BMI) 
and B) triglycerides (in Z score) by attained age with N cases: 2,657 for <50 years, 4,591 50-
60 years, 3,024 60-70 years, and 1,668>70 years. Models were derived from Cox models 
using cubic spline, with knots placed at 5, 35, 65 and 95 centiles. Participants with a BMI 
higher than 40, and with a triglyceride Z score >3 and <-3 were excluded from the respective 























































Incomplete ID, or exclusion of VIP observations for 
individual doublets in the VIP-MPP: 14 observations 
Date of cancer diagnosis ≤ date of health examination:  
26,158 observations 
In subjects with ≥ 2 health observations: selection of the first 
observation with priority given to i) complete data on 
metabolic factors ii) a fasting state  
Extreme values for weight (<35 or >250 kg), height (<100 






Observations in the VHM&PP before the year 1988 due to 
non-fasting status: 77,031 observations 
 
 
Fasting status missing: 29,842 observations 
 
 




843,531 individuals with 1,557,855 observations 
Men recorded with female cancers and women recorded 
with male cancers: 4 individuals 
Older than 100 years at end of follow-up: 302 individuals 
No data on metabolic factors: 487 observations 
 
 
813,927 individuals with 1,423,070 observations 
Non-matching dates: death/emigration ≤ health 
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